1-ethyl-2,3-dihydro-1H-indole-5-sulfonamide → 1-Ethylindoline-6-sulfonamide
반응식
C(N1C2C(=CC(S(N)(=O)=O)=CC=2)CC1)C.[C:16]([N:19]1[C:27]2[C:22](=[CH:23][CH:24]=[C:25]([S:28]([NH2:31])(=[O:30])=[O:29])[CH:26]=2)[CH2:21][CH2:20]1)(=O)[CH3:17]>>[CH2:16]([N:19]1[C:27]2[C:22](=[CH:23][CH:24]=[C:25]([S:28]([NH2:31])(=[O:29])=[O:30])[CH:26]=2)[CH2:21][CH2:20]1)[CH3:17]참가 물질
3
실험 절차
Following a procedure analogous to that for the synthesis of Intermediate 53, 1-acetylindoline-6-sulfonamide (Intermediate 60, 200 mg, 0.83 mmol) was converted to the title compound (50 mg, 27%) after purification using preparative HPLC. 1H NMR (CDCl3) δ 7.37 (d, J=7.5 Hz, 1H), 7.21 (d, J=9.7 Hz, 2H), 3.59 (t, J=8.1 Hz, 2H), 3.28 (q, J=8.1 Hz, 2H), 3.10 (t, J=8.1 Hz, 2H), 1.26-1.22 (m, 3H); MS(ESI+) m/z 227.1 (M+H)+.
출처 및 근거
- ORD 기록
- ord-c5fb41f6878c48b7b112981a1618bf48
- 출처 데이터셋
- uspto-grants-2016_05
- 특허 번호
- US09346795B2
반응 노트
불러오는 중…